These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 6395017)

  • 1. [Treatment of dermatomycosis with naftifin. Therapeutic effectiveness following once and twice daily administration].
    Meinicke K; Striegel C; Weidinger G
    Mykosen; 1984 Dec; 27(12):608-14. PubMed ID: 6395017
    [No Abstract]   [Full Text] [Related]  

  • 2. [Naftifin in severe dermatomycosis--controlled comparison of efficacy with econazole].
    Nolting S; Weidinger G
    Mykosen; 1985 Feb; 28(2):69-76. PubMed ID: 3885027
    [No Abstract]   [Full Text] [Related]  

  • 3. [Naftifin in foot mycoses. Double-blind therapeutic comparison with clotrimazole].
    Haas PJ; Tronnier H; Weidinger G
    Mykosen; 1985 Jan; 28(1):33-40. PubMed ID: 3883160
    [No Abstract]   [Full Text] [Related]  

  • 4. [Multicenter double-blind contralateral comparison of naftifin and clotrimazole cream in patients with dermatophytosis and candidiasis].
    Zaun H; Luszpinski P
    Z Hautkr; 1984 Sep; 59(18):1209-17. PubMed ID: 6388169
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of naftifine (Exoderil) cream in the treatment of dermatophytosis.
    Lee CT; Giam YC; Tan T
    Singapore Med J; 1987 Oct; 28(5):429-31. PubMed ID: 3324355
    [No Abstract]   [Full Text] [Related]  

  • 6. [Double blind, randomized in vivo investigations comparing the antifungals clotrimazole, tolnaftate and naftifine (author's transl)].
    Hantschke D; Reichenberger M
    Mykosen; 1980 Dec; 23(12):657-68. PubMed ID: 7012610
    [No Abstract]   [Full Text] [Related]  

  • 7. New therapeutic approach in skin mycoses: a comparative trial once versus twice daily application of fenticonazole in comparison to miconazole.
    Vannini P; Difonzo EM; Cordaro CI; Sartani A; Panconesi E
    Mycoses; 1988 May; 31(5):280-4. PubMed ID: 3047577
    [No Abstract]   [Full Text] [Related]  

  • 8. [The antifungal agent naftifin. Placebo-controlled therapeutic comparison in tinea pedis].
    Klaschka F; Gartmann H; Weidinger G
    Z Hautkr; 1984 Sep; 59(18):1218-26. PubMed ID: 6388170
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Double-blind comparative study of RO-13-8996 with miconazole in relation to its efficiency and local tolerance in patients with dermatomycosis].
    Arreaza de Arreaza F; Díaz de Torres E; Briceño Maaz T
    Med Cutan Ibero Lat Am; 1984; 12(1):57-61. PubMed ID: 6376980
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Contact allergy to the antifungal agent naftifin].
    Hoting E; Küchmeister B; Hausen BM
    Derm Beruf Umwelt; 1987; 35(4):124-7. PubMed ID: 2959458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Naftifin--laboratory and clinical experience with a new antimycotic from the allylamine group].
    Otcenásek M; Péc J; Moravcík P
    Cas Lek Cesk; 1993 Jun; 132(13):406-9. PubMed ID: 8370053
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Antimycotic effect of naftifin in tinea pedis. Comparative double-blind study with bifonazole].
    Bojanovsky A; Haas P
    Fortschr Med; 1985 Jul; 103(25):677-9. PubMed ID: 3897005
    [No Abstract]   [Full Text] [Related]  

  • 13. [The problem of external therapy used in skin mycosis].
    Tarasenko GN; Patronov IV; Kuz'mina IuV; Tarasenko IuG
    Voen Med Zh; 2004 Aug; 325(8):38-9. PubMed ID: 15471414
    [No Abstract]   [Full Text] [Related]  

  • 14. Naftifine solution (1%) in the treatment of pityriasis versicolor in Zambia.
    Hira SK; Abraham MS; Mwinga A; Kamanga J; Schmidt C
    Mykosen; 1986 Aug; 29(8):378-81. PubMed ID: 3531847
    [No Abstract]   [Full Text] [Related]  

  • 15. [Evaluation of the efficacy of a new antimycotic molecule for topical use: naftifine].
    Albanese G; Giorgetti P; Santagostino L; Di Cintio R; Colombo MD
    G Ital Dermatol Venereol; 1989 May; 124(5):XXXIII-XXXVII. PubMed ID: 2620916
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antifungal activity of SN 105-843 gel in vivo.
    Haroon TS; Qazi AA; Khan KA; Farooqi AH
    J Pak Med Assoc; 1981 Jun; 31(6):123-6. PubMed ID: 6792389
    [No Abstract]   [Full Text] [Related]  

  • 17. Allylamines: topical and oral treatment of dermatomycoses with a new class of antifungal agents.
    Ganzinger U; Stutz A; Petranyi G; Stephen A
    Acta Derm Venereol Suppl (Stockh); 1986; 121():155-60. PubMed ID: 3459341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Naftifine cream 1% compared with miconazole cream 2% in dermatophytosis.
    el Darouti MA; Kalinka P
    Int J Dermatol; 1990 Sep; 29(7):521-2. PubMed ID: 2228386
    [No Abstract]   [Full Text] [Related]  

  • 19. Topical tioconazole in dermatomycosis.
    Kuokkanen K
    Mykosen; 1982 May; 25(5):274-80. PubMed ID: 7048088
    [No Abstract]   [Full Text] [Related]  

  • 20. Naftifine versus miconazole/hydrocortisone in inflammatory dermatophyte infections.
    Nada M; Hanafi S; al-Omari H; Mokhtar M; el-Shamy S; Mühlbacher J
    Int J Dermatol; 1994 Aug; 33(8):570-2. PubMed ID: 7960355
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.